Balaji Narasimhan

Iowa State University

H指数:35

被引数:4,517

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancer

纳米疫苗诱导持久的、功能性的靶向MUC4的T细胞反应以对抗胰腺癌

Acta Biomaterialia

IF9.6

2026-04-170

PRE

A Novel Approach To Integrate Low Impact Development (LID) Modules into the SWAT Model To Facilitate Sustainable Urban Drainage Planning at River Basin Scales

一种将低影响开发（LID）模块整合到SWAT模型中的新方法，以促进流域尺度的可持续城市排水规划

Water Resources Management

IF4.7

2025-12-260

PRE

Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition

尼美沙胺纳米颗粒通过抑制HIF-1α增强胰腺癌对吉西他滨的敏感性

iScience

IF4.1

2025-11-170

OAAI

Elucidating the systemic humoral response and immune microenvironment at the implant interface of the Vaccine Platform for Extended Antigen Release (VPEAR)

JOURNAL OF IMMUNOLOGY

IF3.4

2025-11-010

PRE

Safety and Biocompatibility of a Spray-Dried Influenza Microparticle Vaccine in Mice

喷雾干燥流感微粒子疫苗在 mice 中的安全性与生物相容性

REGENERATIVE ENGINEERING AND TRANSLATIONAL MEDICINE

IF0

2025-09-010

OAAI

Equine Influenza Antigen-Based Particle Vaccine Protects Mice Against Homologous and Heterosubtypic Viral Challenges

马流感抗原基颗粒疫苗保护小鼠抵抗同源和异亚型病毒攻击

Acta Biomaterialia

IF9.6

2025-07-220

PRE

Polyanhydride nanoparticles encapsulating innate sensor agonists activate epithelial and airway cells and reduce Respiratory Syncytial Virus infection in mice

聚酐纳米颗粒包封内源性传感激动剂可激活上皮和气道细胞，并降低小鼠呼吸道合胞病毒感染

Acta Biomaterialia

IF9.6

2025-05-240

PRE

Next-generation nanovaccine induces durable immunity and protects against SARS-CoV-2

ACTA BIOMATERIALIA

IF9.6

2024-07-010

PRE

Polyanhydride nanovaccine against H3N2 influenza A virus generates mucosal resident and systemic immunity promoting protection

NPJ VACCINES

IF6.5

2024-05-311

OAAI

Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-06-093

OAAI

Just right combinations of adjuvants with nanoscale carriers activate aged dendritic cells without overt inflammation

IMMUNITY & AGEING

IF5.6

2023-03-094

OAAI

Structural Stability and Antigenicity of Universal Equine H3N8 Hemagglutinin Trimer upon Release from Polyanhydride Nanoparticles and Pentablock Copolymer Hydrogels

ACS BIOMATERIALS SCIENCE & ENGINEERING

IF5.5

2022-05-236

PRE

Immunization with a mucosal, post fusion F/G protein-based polyanhydride nanovaccine protects against BRSV infection in neonatal calves

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

PRE

Bovine NK-lysin peptides exert potent antimicrobial activity against multidrug-resistant Salmonella outbreak isolates

SCIENTIFIC REPORTS

IF3.9

2021-09-2910

OAAI

Self-assembling synthetic nanoadjuvant scaffolds cross-link B cell receptors and represent new platform technology for therapeutic antibody production

SCIENCE ADVANCES

IF12.5

2021-08-0610

OAAI

Functionalized polyanhydride nanoparticles for improved treatment of mitochondrial dysfunction

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS

IF3.4

2021-07-2712

PREAI

Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus

JOURNAL OF IMMUNOLOGY

IF3.4

2021-05-0113

Nanotechnology-mediated therapeutic strategies against synucleinopathies in neurodegenerative disease

纳米技术介导的神经退行性疾病突触核蛋白病治疗策略

CURRENT OPINION IN CHEMICAL ENGINEERING

IF6.8

2021-03-016

OAAI

Nanomedicines to counter microbial barriers and antimicrobial resistance

CURRENT OPINION IN CHEMICAL ENGINEERING

IF6.8

2021-03-018

OAAI

Enzyme Immunoassay-Based Platform for Accurate Detection of Serum Pathological α-Synuclein in Parkinson's Disease Patients

ACS CHEMICAL NEUROSCIENCE

IF3.9

2020-11-168

PREAI

Balaji Narasimhan

个人简介

教育背景

工作经历

荣誉奖项

研究方向